These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 28294315)

  • 1. Predictors of incident obesity phenotype in nonobese healthy adults.
    Eftekharzadeh A; Asghari G; Serahati S; Hosseinpanah F; Azizi A; Barzin M; Mirmiran P; Azizi F
    Eur J Clin Invest; 2017 May; 47(5):357-365. PubMed ID: 28294315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between transition from metabolically healthy obesity to metabolic syndrome, and incidence of cardiovascular disease: Tehran lipid and glucose study.
    Hosseinpanah F; Tasdighi E; Barzin M; Mahdavi M; Ghanbarian A; Valizadeh M; Azizi F
    PLoS One; 2020; 15(9):e0239164. PubMed ID: 32947607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular Risk Factors Associated With the Metabolically Healthy Obese (MHO) Phenotype Compared to the Metabolically Unhealthy Obese (MUO) Phenotype in Children.
    Genovesi S; Antolini L; Orlando A; Gilardini L; Bertoli S; Giussani M; Invitti C; Nava E; Battaglino MG; Leone A; Valsecchi MG; Parati G
    Front Endocrinol (Lausanne); 2020; 11():27. PubMed ID: 32117055
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiovascular risk in different obesity phenotypes over a decade follow-up: Tehran Lipid and Glucose Study.
    Mirzaei B; Abdi H; Serahati S; Barzin M; Niroomand M; Azizi F; Hosseinpanah F
    Atherosclerosis; 2017 Mar; 258():65-71. PubMed ID: 28213199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural course of metabolically healthy phenotype and risk of developing Cardiometabolic diseases: a three years follow-up study.
    Elías-López D; Vargas-Vázquez A; Mehta R; Cruz Bautista I; Del Razo Olvera F; Gómez-Velasco D; Almeda Valdes P; Aguilar-Salinas CA;
    BMC Endocr Disord; 2021 Apr; 21(1):85. PubMed ID: 33910543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolically healthy obesity and risk of incident CKD.
    Hashimoto Y; Tanaka M; Okada H; Senmaru T; Hamaguchi M; Asano M; Yamazaki M; Oda Y; Hasegawa G; Toda H; Nakamura N; Fukui M
    Clin J Am Soc Nephrol; 2015 Apr; 10(4):578-83. PubMed ID: 25635035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and predictors of metabolically healthy obesity in adolescents: findings from the national "Jeeluna" study in Saudi-Arabia.
    Nasreddine L; Tamim H; Mailhac A; AlBuhairan FS
    BMC Pediatr; 2018 Aug; 18(1):281. PubMed ID: 30139344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Transition in Metabolic Health and Obesity on the Incident Chronic Kidney Disease: A Nationwide Cohort Study.
    Cho YK; Lee J; Kim HS; Park JY; Lee WJ; Kim YJ; Jung CH
    J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31967306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between metabolically healthy obesity and metabolically unhealthy obesity by different definitions among Mexican children.
    Evia-Viscarra ML; Guardado-Mendoza R
    J Pediatr Endocrinol Metab; 2020 Feb; 33(2):215-222. PubMed ID: 31834862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No Difference in Lactoferrin Levels between Metabolically Healthy and Unhealthy Obese Women.
    Jamka M; Krzyżanowska-Jankowska P; Mądry E; Lisowska A; Bogdański P; Walkowiak J
    Nutrients; 2019 Aug; 11(9):. PubMed ID: 31443387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of the transition from metabolically healthy obesity to unhealthy obesity.
    Gilardini L; Zambon A; Soranna D; Croci M; Invitti C
    Eat Weight Disord; 2018 Dec; 23(6):739-744. PubMed ID: 30374903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mediterranean diet and mortality risk in metabolically healthy obese and metabolically unhealthy obese phenotypes.
    Park YM; Steck SE; Fung TT; Zhang J; Hazlett LJ; Han K; Merchant AT
    Int J Obes (Lond); 2016 Oct; 40(10):1541-1549. PubMed ID: 27339604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of type 2 diabetes, hypertension, and dyslipidemia in metabolically healthy obese and non-obese.
    Fingeret M; Marques-Vidal P; Vollenweider P
    Nutr Metab Cardiovasc Dis; 2018 Oct; 28(10):1036-1044. PubMed ID: 30139688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolically healthy/unhealthy components may modify bone mineral density in obese people.
    Mirzababaei A; Mirzaei K; Khorrami-Nezhad L; Maghbooli Z; Keshavarz SA
    Arch Osteoporos; 2017 Oct; 12(1):95. PubMed ID: 29082431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Nested Case-Control Study of Metabolically Defined Body Size Phenotypes and Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Murphy N; Cross AJ; Abubakar M; Jenab M; Aleksandrova K; Boutron-Ruault MC; Dossus L; Racine A; Kühn T; Katzke VA; Tjønneland A; Petersen KE; Overvad K; Quirós JR; Jakszyn P; Molina-Montes E; Dorronsoro M; Huerta JM; Barricarte A; Khaw KT; Wareham N; Travis RC; Trichopoulou A; Lagiou P; Trichopoulos D; Masala G; Krogh V; Tumino R; Vineis P; Panico S; Bueno-de-Mesquita HB; Siersema PD; Peeters PH; Ohlsson B; Ericson U; Palmqvist R; Nyström H; Weiderpass E; Skeie G; Freisling H; Kong SY; Tsilidis K; Muller DC; Riboli E; Gunter MJ
    PLoS Med; 2016 Apr; 13(4):e1001988. PubMed ID: 27046222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive metabolic profiling of the metabolically healthy obesity phenotype.
    Telle-Hansen VH; Christensen JJ; Formo GA; Holven KB; Ulven SM
    Lipids Health Dis; 2020 May; 19(1):90. PubMed ID: 32386512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early determinants of metabolically healthy obesity in young adults: study of the Northern Finland Birth Cohort 1966.
    Nedelec R; Jokelainen J; Miettunen J; Ruokonen A; Herzig KH; Männikkö M; Järvelin MR; Sebert S
    Int J Obes (Lond); 2018 Oct; 42(10):1704-1714. PubMed ID: 29795454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolically healthy obesity and the risk for subclinical atherosclerosis.
    Kim TJ; Shin HY; Chang Y; Kang M; Jee J; Choi YH; Ahn HS; Ahn SH; Son HJ; Ryu S
    Atherosclerosis; 2017 Jul; 262():191-197. PubMed ID: 28385392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of chronic kidney disease in a metabolically healthy obese population.
    Jung CH; Lee MJ; Kang YM; Hwang JY; Kim EH; Park JY; Kim HK; Lee WJ
    Kidney Int; 2015 Oct; 88(4):843-50. PubMed ID: 26108064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FAT-FREE MASS, METABOLICALLY HEALTHY OBESITY, AND TYPE 2 DIABETES IN SEVERELY OBESE ASIAN ADULTS.
    Pramyothin P; Limpattanachart V; Dawilai S; Sarasak R; Sukaruttanawong C; Chaiyasoot K; Keawtanom S; Yamwong P
    Endocr Pract; 2017 Aug; 23(8):915-922. PubMed ID: 28614006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.